Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2021

View Archived Issues

A virus-specific nanobody lowers latent viral loads in HCMV-infected cells

Clinical hold extended for ORTHO-R phase I/II study

Genexine describes anti-TAA, anti-PD-L1, TNFRSF9 ligand fusion proteins

Sumitomo Dainippon Pharma Oncology patents serine/threonine kinase Nek2 inhibitors

New SREBP inhibitors identified at Capulus Therapeutics

Shanghai Bowei Biological Technology, collaborators divulge polynucleotides for expressing HPV 51L1

KIN-001 for COVID-19 shows preclinical antiviral, anti-inflammatory and antifibrotic activity

APP gene mutation causes autosomal dominant Alzheimer's disease

Salicylanilide compounds show promise for treating COVID-19

Improved serum metabolic profile and symptoms in patients with ALS treated with ILB

AAV gene therapy targeting CaMKII protects retinal ganglion cells, preserves vision

ACMT reports on patients becoming ill from use of ivermectin for COVID-19

Bavarian Nordic studies ABNCoV2 as COVID-19 booster vaccine in phase II

FDA clears IND for clinical trials of siroquine for newly diagnosed GBM

Phase I data reported for GDC-3280 in healthy subjects

Cytokine-induced JAK/STAT signaling plays role in cachexia

KalVista gains clinical trial approvals for phase II trial of KVD-824 for HAE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...